对于持续不受控制的哮喘患者，在标准疗法中加入阿奇霉素可提高1年后的临床缓解率。

IF 19.6 1区医学 Q1 MEDICINE, GENERAL & INTERNAL

Annals of Internal Medicine Pub Date : 2024-10-01 DOI:10.7326/ANNALS-24-02230-JC

Christine F McDonald

引用次数: 0

摘要

来源引用：Thomas D、McDonald VM、Stevens S 等：阿奇霉素对哮喘持续失控成人患者哮喘缓解的影响：随机、双匿名、安慰剂对照试验的二次分析。Chest.2024;166:262-270.38431051.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

In persistent uncontrolled asthma, adding azithromycin to standard therapy increased clinical remission rates at 1 y.

Source citation: Thomas D, McDonald VM, Stevens S, et al. Effect of azithromycin on asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomized, double-anonymized, placebo-controlled trial. Chest. 2024;166:262-270. 38431051.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annals of Internal Medicine 医学-医学：内科

CiteScore

23.90

自引率

1.80%

发文量

1136

审稿时长

3-8 weeks

期刊介绍： Established in 1927 by the American College of Physicians (ACP), Annals of Internal Medicine is the premier internal medicine journal. Annals of Internal Medicine’s mission is to promote excellence in medicine, enable physicians and other health care professionals to be well informed members of the medical community and society, advance standards in the conduct and reporting of medical research, and contribute to improving the health of people worldwide. To achieve this mission, the journal publishes a wide variety of original research, review articles, practice guidelines, and commentary relevant to clinical practice, health care delivery, public health, health care policy, medical education, ethics, and research methodology. In addition, the journal publishes personal narratives that convey the feeling and the art of medicine.